Cargando…
microRNAs targeting cellular cholesterol: implications for combating anticancer drug resistance
Over sixty percent of all mammalian protein-coding genes are estimated to be regulated by microRNAs (miRNAs), and unsurprisingly miRNA dysregulation has been linked with cancer. Aberrant miRNA expression in cancer cells has been linked with tumourigenesis and drug resistance. In the past decade, inc...
Autores principales: | Monchusi, Bernice, Kaur, Mandeep |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289906/ https://www.ncbi.nlm.nih.gov/pubmed/32577155 http://dx.doi.org/10.18632/genesandcancer.202 |
Ejemplares similares
-
The Regulation of Reverse Cholesterol Transport and Cellular Cholesterol Homeostasis by MicroRNAs
por: DiMarco, Diana M., et al.
Publicado: (2015) -
Methyl pyruvate protects a normal lung fibroblast cell line from irinotecan-induced cell death: Potential use as adjunctive to chemotherapy
por: Monchusi, Bernice, et al.
Publicado: (2017) -
Alkylating anticancer agents and their relations to microRNAs
por: Biersack, Bernhard
Publicado: (2019) -
Mechanisms of Action And Clinical Implications of MicroRNAs in the Drug Resistance of Gastric Cancer
por: Liu, Ying, et al.
Publicado: (2021) -
Network-based identification of microRNAs as potential pharmacogenomic biomarkers for anticancer drugs
por: Li, Jie, et al.
Publicado: (2016)